NPI: 1710064811 · WEST ALLIS, WI 53227 · Clinical Medical Laboratory · NPI assigned 11/01/2006
Authorized official RICHARDSON, KARA controls 20+ related entities in our dataset. Read more
| Authorized Official | RICHARDSON, KARA (ASSISTANT TREASURER) |
| NPI Enumeration Date | 11/01/2006 |
Other providers sharing the same authorized official: RICHARDSON, KARA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 704,807 | $11.71M |
| 2019 | 678,214 | $10.20M |
| 2020 | 627,379 | $10.06M |
| 2021 | 836,058 | $15.85M |
| 2022 | 767,246 | $13.58M |
| 2023 | 973,588 | $15.28M |
| 2024 | 1,364,545 | $22.06M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 112,923 | 101,174 | $8.46M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 179,197 | 167,500 | $6.28M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 178,828 | 167,034 | $6.22M |
| 84443 | Thyroid stimulating hormone (TSH) | 236,679 | 221,566 | $3.30M |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 102,307 | 95,399 | $3.29M |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 107,395 | 99,410 | $3.16M |
| 80053 | Comprehensive metabolic panel | 343,050 | 313,254 | $3.12M |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 152,005 | 144,405 | $3.07M |
| 80050 | General health panel | 70,941 | 64,439 | $3.03M |
| 80061 | Lipid panel | 306,766 | 289,177 | $2.95M |
| 81513 | 32,468 | 30,425 | $2.70M | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 110,615 | 104,731 | $2.42M |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 78,370 | 73,678 | $2.32M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 301,317 | 272,275 | $1.86M |
| 83036 | Hemoglobin; glycosylated (A1C) | 254,934 | 241,632 | $1.84M |
| 87481 | 33,341 | 30,955 | $1.82M | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 92,683 | 83,824 | $1.45M |
| 86480 | 26,084 | 24,881 | $1.43M | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 171,444 | 156,483 | $1.29M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 18,334 | 17,233 | $1.28M |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 30,366 | 27,828 | $1.25M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 37,490 | 34,256 | $1.22M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 26,925 | 23,203 | $1.21M |
| 87507 | 3,407 | 3,181 | $934K | |
| 86803 | 65,497 | 61,945 | $862K | |
| 82607 | 63,007 | 59,619 | $784K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 94,521 | 86,408 | $670K |
| 86235 | 7,065 | 5,076 | $634K | |
| 83970 | 20,153 | 19,162 | $619K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1,956 | 1,784 | $617K |
| 82728 | 58,609 | 55,516 | $598K | |
| 87529 | 9,859 | 8,302 | $584K | |
| 84439 | 69,906 | 65,034 | $545K | |
| 87340 | 51,909 | 48,619 | $519K | |
| 82746 | 42,996 | 40,624 | $518K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 9,478 | 7,461 | $512K |
| 87563 | 20,125 | 18,898 | $505K | |
| 86003 | 11,381 | 8,846 | $504K | |
| 80081 | 8,500 | 7,320 | $501K | |
| 83655 | 41,235 | 39,765 | $485K | |
| 85027 | 82,892 | 77,136 | $482K | |
| 84153 | 32,052 | 30,274 | $473K | |
| 87186 | 52,144 | 47,076 | $467K | |
| 87081 | 72,285 | 68,827 | $464K | |
| 84702 | 37,428 | 28,051 | $445K | |
| 83550 | 59,396 | 56,264 | $433K | |
| 86780 | 37,268 | 34,514 | $417K | |
| 83880 | 15,080 | 13,065 | $411K | |
| 84403 | 15,713 | 14,764 | $354K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 11,379 | 10,808 | $353K |
| 82570 | 83,678 | 78,163 | $352K | |
| 0240U | 5,730 | 5,437 | $347K | |
| 83540 | 63,201 | 59,824 | $343K | |
| 82043 | 75,430 | 71,829 | $341K | |
| 80074 | 10,790 | 9,985 | $330K | |
| 86762 | 27,471 | 25,437 | $329K | |
| 87077 | 40,286 | 37,045 | $299K | |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 573 | 513 | $291K |
| 84481 | 22,176 | 20,646 | $280K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 7,551 | 7,050 | $268K |
| 86592 | 67,013 | 63,308 | $267K | |
| 87088 | 34,215 | 32,072 | $259K | |
| 86706 | 25,711 | 24,216 | $259K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 1,735 | 1,644 | $255K |
| 87902 | 1,115 | 1,039 | $254K | |
| 86787 | 25,567 | 24,018 | $243K | |
| 82784 | 18,544 | 16,863 | $241K | |
| 86140 | 50,943 | 45,261 | $231K | |
| 86038 | 20,388 | 19,147 | $229K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 2,012 | 1,838 | $224K |
| 81001 | 82,062 | 75,792 | $223K | |
| 84146 | 13,560 | 12,655 | $222K | |
| 82105 | 14,246 | 13,489 | $217K | |
| 83001 | 13,175 | 12,512 | $217K | |
| 83735 | 37,633 | 31,453 | $215K | |
| 86704 | 17,807 | 16,778 | $196K | |
| 87522 | Neg quan hep c or qual rna | 4,840 | 4,587 | $191K |
| 87480 | 9,853 | 9,112 | $189K | |
| 87510 | 9,848 | 9,107 | $184K | |
| 82670 | 8,816 | 8,261 | $182K | |
| 83516 | 11,618 | 9,465 | $180K | |
| 87070 | 23,870 | 21,506 | $180K | |
| 87536 | 2,405 | 2,273 | $179K | |
| 87660 | 9,785 | 9,054 | $173K | |
| 80076 | 23,619 | 22,101 | $168K | |
| 87641 | 6,411 | 5,467 | $167K | |
| 86850 | 30,061 | 28,320 | $166K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 4,140 | 2,466 | $146K |
| 88341 | 2,207 | 1,954 | $143K | |
| 85610 | 40,736 | 27,406 | $139K | |
| 82274 | 11,812 | 11,304 | $138K | |
| 87808 | 10,824 | 9,838 | $138K | |
| 87493 | 4,583 | 4,227 | $136K | |
| 83013 | 3,383 | 3,207 | $132K | |
| 82950 | 26,039 | 24,537 | $120K | |
| 88342 | 6,031 | 5,505 | $118K | |
| 86665 | 4,162 | 3,518 | $116K | |
| 86160 | 6,862 | 5,908 | $116K | |
| 83002 | 8,490 | 7,946 | $116K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 903 | 860 | $114K |
| 83690 | 17,812 | 16,597 | $111K | |
| 86200 | 9,633 | 9,204 | $108K | |
| 87521 | Neg quan hep c or qual rna | 3,384 | 3,143 | $108K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 687 | 663 | $107K |
| 84144 | 6,175 | 5,410 | $106K | |
| 86696 | 5,515 | 5,131 | $104K | |
| 87640 | 5,323 | 4,719 | $104K | |
| 83020 | 11,590 | 10,796 | $103K | |
| 85652 | 42,026 | 37,462 | $101K | |
| 81329 | 1,265 | 1,167 | $101K | |
| 86376 | 8,445 | 8,022 | $100K | |
| 84270 | 5,468 | 5,229 | $99K | |
| 87210 | 20,840 | 19,096 | $99K | |
| 86364 | 8,261 | 7,670 | $97K | |
| 87505 | 1,200 | 1,151 | $97K | |
| 82533 | 6,873 | 5,534 | $95K | |
| 86618 | 6,174 | 5,864 | $95K | |
| 88307 | 1,489 | 1,392 | $94K | |
| 88344 | 1,025 | 833 | $92K | |
| 86146 | 2,489 | 2,211 | $91K | |
| 88304 | 6,292 | 5,813 | $90K | |
| 88142 | 6,213 | 5,835 | $89K | |
| 86147 | 3,268 | 2,681 | $88K | |
| 87517 | 2,142 | 2,040 | $86K | |
| 84484 | 7,289 | 6,494 | $85K | |
| 84156 | 29,058 | 25,565 | $85K | |
| 86800 | 6,304 | 6,015 | $85K | |
| 84550 | 22,332 | 20,685 | $83K | |
| 87205 | 20,970 | 18,858 | $82K | |
| 88312 | 3,884 | 3,576 | $82K | |
| 86901 | 25,875 | 24,255 | $81K | |
| 84425 | 4,726 | 4,493 | $80K | |
| 86431 | 14,922 | 14,091 | $79K | |
| 83520 | 5,562 | 4,989 | $79K | |
| 80197 | 7,181 | 4,493 | $76K | |
| 83721 | 10,423 | 9,339 | $75K | |
| 86225 | 6,567 | 5,991 | $75K | |
| 83525 | 7,322 | 7,001 | $72K | |
| 82951 | 5,859 | 5,567 | $72K | |
| 84165 | 7,448 | 6,878 | $72K | |
| 81003 | 35,083 | 32,908 | $71K | |
| 86900 | 24,848 | 23,376 | $70K | |
| 86334 | 3,716 | 3,431 | $69K | |
| 82330 | 5,829 | 5,148 | $68K | |
| 88112 | 1,991 | 1,861 | $67K | |
| 82627 | 4,003 | 3,808 | $66K | |
| 82677 | 3,229 | 2,945 | $64K | |
| 84445 | 2,080 | 1,991 | $63K | |
| 82565 | 14,385 | 12,132 | $63K | |
| 86769 | 1,768 | 1,685 | $60K | |
| 86336 | 3,442 | 3,145 | $60K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 772 | 702 | $60K |
| 82024 | 2,050 | 1,878 | $59K | |
| 80164 | 5,336 | 4,990 | $59K | |
| 86695 | 4,480 | 4,137 | $59K | |
| 83521 | 2,497 | 2,261 | $58K | |
| 82550 | 10,571 | 9,249 | $58K | |
| 84100 | 15,771 | 13,461 | $58K | |
| 87449 | 5,031 | 4,680 | $55K | |
| 84402 | 2,600 | 2,466 | $55K | |
| 87075 | 6,287 | 5,299 | $54K | |
| 86039 | 5,534 | 5,180 | $53K | |
| 84460 | 11,046 | 9,281 | $51K | |
| 83498 | 2,507 | 2,344 | $50K | |
| 81374 | 1,116 | 1,052 | $50K | |
| 87147 | 9,272 | 8,608 | $50K | |
| 87427 | 4,731 | 4,429 | $50K | |
| 83993 | 3,517 | 3,298 | $49K | |
| 88173 | 1,342 | 1,233 | $49K | |
| 83615 | 9,523 | 7,949 | $49K | |
| 84703 | 6,889 | 6,544 | $48K | |
| 87040 | 3,034 | 2,664 | $48K | |
| 85379 | 5,406 | 5,163 | $47K | |
| 82785 | 3,796 | 3,551 | $47K | |
| 87497 | 1,305 | 829 | $46K | |
| 82652 | 2,011 | 1,856 | $45K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,491 | 1,420 | $45K |
| 80177 | 4,018 | 3,760 | $44K | |
| 85730 | 8,836 | 8,110 | $43K | |
| 82088 | 1,204 | 1,146 | $42K | |
| 87799 | 1,275 | 902 | $42K | |
| 87045 | 4,621 | 4,328 | $42K | |
| 81025 | 5,541 | 5,242 | $40K | |
| 84450 | 8,609 | 7,067 | $40K | |
| 84207 | 1,743 | 1,669 | $39K | |
| 82378 | 2,851 | 2,557 | $38K | |
| 84630 | 3,771 | 3,596 | $37K | |
| 87338 | 2,532 | 2,407 | $36K | |
| 88360 | 506 | 451 | $36K | |
| 86304 | 2,231 | 2,051 | $36K | |
| 88185 | 400 | 352 | $35K | |
| 80069 | 5,312 | 4,526 | $35K | |
| 84480 | 3,185 | 2,989 | $34K | |
| 85018 | 15,002 | 14,413 | $34K | |
| 82247 | 7,249 | 4,868 | $33K | |
| 87209 | 2,115 | 1,927 | $33K | |
| 86735 | 2,685 | 2,490 | $33K | |
| 82248 | 7,697 | 6,304 | $33K | |
| 83921 | 1,963 | 1,855 | $32K | |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 128 | 103 | $31K |
| 86341 | 1,298 | 1,067 | $31K | |
| 85390 | 3,306 | 2,975 | $31K | |
| 85613 | 3,328 | 2,956 | $31K | |
| 86765 | 2,947 | 2,768 | $30K | |
| 82140 | 2,516 | 2,253 | $30K | |
| 88262 | 272 | 242 | $30K | |
| 86870 | 828 | 740 | $30K | |
| 86361 | 1,333 | 1,268 | $28K | |
| 86708 | 2,810 | 2,635 | $28K | |
| 80055 | 1,625 | 1,442 | $28K | |
| 82977 | 4,949 | 4,454 | $28K | |
| 82150 | 4,603 | 4,269 | $27K | |
| 84305 | 1,616 | 1,556 | $27K | |
| 82947 | 7,688 | 6,950 | $27K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 3,025 | 2,884 | $27K |
| 84166 | 1,724 | 1,602 | $25K | |
| 86300 | 1,085 | 954 | $25K | |
| 87625 | 914 | 840 | $25K | |
| 84244 | 1,320 | 1,265 | $25K | |
| 80175 | 2,228 | 2,087 | $24K | |
| 86258 | 1,636 | 1,426 | $24K | |
| 82390 | 2,568 | 2,401 | $24K | |
| 86381 | 1,482 | 1,434 | $23K | |
| 86255 | 1,067 | 766 | $23K | |
| 82103 | 2,085 | 1,923 | $23K | |
| 83630 | 1,804 | 1,705 | $22K | |
| 85046 | 4,660 | 4,369 | $22K | |
| 82239 | 1,462 | 1,195 | $22K | |
| 84145 | 966 | 893 | $22K | |
| 80178 | 3,918 | 3,567 | $22K | |
| 82077 | 1,719 | 1,490 | $21K | |
| 86141 | 1,752 | 1,630 | $21K | |
| 86705 | 1,892 | 1,800 | $20K | |
| 99000 | 6,681 | 3,464 | $20K | |
| 85014 | 9,311 | 8,661 | $20K | |
| 82952 | 5,311 | 5,084 | $20K | |
| 84202 | 1,364 | 1,317 | $20K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 794 | 599 | $19K |
| 86677 | 2,351 | 2,252 | $19K | |
| 86644 | 1,421 | 1,112 | $19K | |
| 84681 | 1,905 | 1,820 | $19K | |
| 87046 | 4,727 | 4,422 | $18K | |
| 85732 | 3,292 | 2,966 | $18K | |
| 82657 | 999 | 896 | $18K | |
| 81229 | 95 | 93 | $18K | |
| 87177 | 2,163 | 1,965 | $17K | |
| 83883 | 938 | 809 | $17K | |
| 85245 | 1,028 | 936 | $16K | |
| 87102 | 2,360 | 2,180 | $16K | |
| 84432 | 1,185 | 1,144 | $16K | |
| 86617 | 683 | 605 | $16K | |
| 84134 | 2,093 | 1,836 | $15K | |
| 83835 | 1,069 | 976 | $15K | |
| 84132 | 3,800 | 3,204 | $15K | |
| 86015 | 1,592 | 1,541 | $15K | |
| 83090 | 1,068 | 962 | $14K | |
| 80047 | 1,604 | 1,458 | $14K | |
| 86301 | 918 | 825 | $14K | |
| 86709 | 1,641 | 1,517 | $14K | |
| 86008 | 228 | 200 | $14K | |
| 88230 | 210 | 181 | $14K | |
| 80143 | 964 | 876 | $13K | |
| 82164 | 1,060 | 1,005 | $13K | |
| 84155 | 4,467 | 4,138 | $13K | |
| 80179 | 919 | 837 | $12K | |
| 82610 | 1,005 | 924 | $12K | |
| 86694 | 893 | 830 | $12K | |
| 82525 | 1,146 | 1,081 | $12K | |
| 88237 | 161 | 145 | $12K | |
| 88184 | 420 | 370 | $11K | |
| 83605 | 1,117 | 892 | $11K | |
| 84080 | 993 | 939 | $11K | |
| 82653 | 611 | 586 | $11K | |
| 81240 | 337 | 302 | $10K | |
| 86849 | 214 | 203 | $10K | |
| 88275 | 201 | 186 | $10K | |
| 82803 | 427 | 381 | $10K | |
| 86645 | 934 | 870 | $10K | |
| 82397 | 776 | 752 | $10K | |
| 84466 | 1,052 | 976 | $10K | |
| 85576 | 329 | 283 | $10K | |
| 87800 | 469 | 351 | $9K | |
| 87076 | 1,192 | 1,081 | $9K | |
| 84478 | 1,980 | 1,685 | $9K | |
| 86308 | 1,963 | 1,841 | $9K | |
| 80156 | 753 | 726 | $9K | |
| 84436 | 1,514 | 1,327 | $9K | |
| 88271 | 196 | 179 | $9K | |
| 86593 | 2,298 | 2,125 | $9K | |
| 84520 | 2,434 | 2,198 | $8K | |
| 81401 | 270 | 247 | $8K | |
| 85246 | 538 | 484 | $8K | |
| 83010 | 782 | 720 | $8K | |
| 82040 | 2,096 | 1,968 | $8K | |
| 84163 | 616 | 591 | $7K | |
| 80299 | 270 | 246 | $7K | |
| 85049 | 1,840 | 972 | $7K | |
| 82310 | 1,688 | 1,589 | $7K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 482 | 460 | $7K |
| 89051 | 1,422 | 994 | $7K | |
| 84075 | 1,604 | 1,412 | $7K | |
| 82465 | 1,773 | 1,670 | $7K | |
| 81479 | Unlisted molecular pathology procedure | 127 | 104 | $7K |
| 82962 | 2,037 | 1,068 | $7K | |
| 85240 | 615 | 555 | $6K | |
| 82340 | 1,197 | 1,137 | $6K | |
| 85660 | 1,214 | 1,124 | $6K | |
| 82157 | 304 | 286 | $6K | |
| 80183 | 572 | 539 | $6K | |
| 81243 | 182 | 173 | $6K | |
| 84238 | 200 | 194 | $6K | |
| 36415 | Collection of venous blood by venipuncture | 14,427 | 11,378 | $6K |
| 83519 | 250 | 201 | $6K | |
| 80202 | 451 | 201 | $6K | |
| 87015 | 1,203 | 800 | $5K | |
| 86777 | 393 | 366 | $5K | |
| 85670 | 3,194 | 2,823 | $5K | |
| 80185 | 414 | 376 | $5K | |
| 85306 | 366 | 326 | $5K | |
| 85307 | 361 | 322 | $4K | |
| 85598 | 293 | 263 | $4K | |
| 82104 | 398 | 383 | $4K | |
| 87116 | 461 | 337 | $4K | |
| 84300 | 998 | 936 | $4K | |
| 84590 | 474 | 463 | $4K | |
| 82542 | 248 | 208 | $4K | |
| 87350 | 389 | 374 | $4K | |
| 82166 | 296 | 292 | $4K | |
| 87150 | 116 | 107 | $4K | |
| 83695 | 561 | 487 | $4K | |
| 87101 | 490 | 474 | $4K | |
| 86256 | 312 | 280 | $4K | |
| 85303 | 324 | 295 | $4K | |
| 86335 | 162 | 146 | $4K | |
| 88313 | 167 | 156 | $3K | |
| 82365 | 320 | 313 | $3K | |
| 87106 | 379 | 347 | $3K | |
| 85247 | 203 | 199 | $3K | |
| 87807 | 255 | 236 | $3K | |
| 88264 | 29 | 27 | $3K | |
| 87206 | 648 | 524 | $3K | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 614 | 570 | $3K |
| 82668 | 214 | 200 | $3K | |
| 83718 | 424 | 393 | $3K | |
| 86036 | 321 | 310 | $3K | |
| 87468 | 103 | 94 | $3K | |
| 81206 | 26 | 26 | $3K | |
| 87484 | 97 | 89 | $3K | |
| 83789 | 136 | 123 | $3K | |
| 86778 | 172 | 156 | $2K | |
| 88302 | 166 | 149 | $2K | |
| 81256 | 56 | 53 | $2K | |
| 89060 | 313 | 294 | $2K | |
| 81050 | 697 | 659 | $2K | |
| 84182 | 28 | 25 | $2K | |
| 82731 | 29 | 25 | $2K | |
| 82085 | 257 | 244 | $2K | |
| 86060 | 261 | 247 | $2K | |
| 86707 | 196 | 193 | $2K | |
| 80235 | 122 | 111 | $2K | |
| 84446 | 190 | 189 | $2K | |
| 86162 | 115 | 106 | $2K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 15 | 15 | $2K |
| 82747 | 120 | 115 | $2K | |
| 86832 | 14 | 13 | $2K | |
| 87593 | 44 | 37 | $1K | |
| 82787 | 100 | 99 | $1K | |
| 86360 | 40 | 37 | $1K | |
| 81015 | 553 | 520 | $1K | |
| 84154 | 76 | 72 | $1K | |
| 86833 | 13 | 12 | $1K | |
| 82232 | 110 | 103 | $1K | |
| 83935 | 238 | 219 | $1K | |
| 87176 | 260 | 236 | $1K | |
| 87109 | 84 | 81 | $1K | |
| 87181 | 103 | 89 | $1K | |
| 82261 | 66 | 60 | $1K | |
| 87324 | 98 | 93 | $906.37 | |
| 88300 | 78 | 75 | $813.38 | |
| 86337 | 53 | 46 | $799.17 | |
| 83014 | 87 | 79 | $776.71 | |
| 82530 | 56 | 54 | $744.64 | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 193 | 173 | $715.65 |
| G0143 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under physician supervision | 87 | 86 | $713.05 |
| 99001 | 155 | 151 | $708.31 | |
| 88333 | 39 | 36 | $704.36 | |
| 85300 | 66 | 66 | $703.39 | |
| 86359 | 26 | 25 | $690.86 | |
| 88311 | 347 | 282 | $689.44 | |
| 87469 | 28 | 24 | $687.74 | |
| 82985 | 51 | 51 | $687.19 | |
| 86682 | 54 | 53 | $635.62 | |
| 81270 | 14 | 14 | $616.27 | |
| 85048 | 310 | 246 | $614.22 | |
| 84133 | 162 | 142 | $584.51 | |
| 84482 | 59 | 54 | $583.95 | |
| 87999 | 14 | 13 | $575.51 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 865 | 512 | $554.79 |
| 84295 | 111 | 38 | $486.72 | |
| 86077 | 18 | 16 | $471.02 | |
| 83930 | 87 | 79 | $433.06 | |
| 84597 | 42 | 40 | $414.27 | |
| 87107 | 41 | 37 | $320.42 | |
| 82955 | 39 | 38 | $292.17 | |
| 84255 | 13 | 12 | $269.76 | |
| 87425 | 18 | 13 | $266.40 | |
| 86041 | 26 | 24 | $246.74 | |
| 82626 | 13 | 12 | $214.13 | |
| 82017 | 12 | 12 | $167.02 | |
| 87385 | 13 | 12 | $144.03 | |
| 80051 | 18 | 15 | $135.31 | |
| 80184 | 13 | 13 | $129.82 | |
| 87341 | 15 | 13 | $125.81 | |
| 82575 | 15 | 14 | $125.45 | |
| 86666 | 15 | 12 | $113.47 | |
| 82172 | 12 | 12 | $112.28 | |
| 82180 | 12 | 12 | $105.82 | |
| 84560 | 26 | 25 | $105.00 | |
| 86753 | 15 | 12 | $99.95 | |
| 80201 | 14 | 13 | $99.23 | |
| 80203 | 12 | 12 | $90.10 | |
| 86886 | 15 | 14 | $87.81 | |
| 87207 | 12 | 12 | $76.68 | |
| 80321 | 227 | 209 | $76.00 | |
| 84479 | 13 | 13 | $72.97 | |
| 84105 | 12 | 12 | $56.65 | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 133 | 76 | $52.08 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 62 | 59 | $12.92 |
| 36416 | 12 | 12 | $6.11 | |
| 80325 | 29 | 24 | $0.00 | |
| 80348 | 294 | 194 | $0.00 | |
| 80349 | 33 | 30 | $0.00 |